Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $556.34 million. The enterprise value is $761.08 million.
| Market Cap | 556.34M |
| Enterprise Value | 761.08M |
Important Dates
The next confirmed earnings date is Friday, May 24, 2024, before market open.
| Earnings Date | May 24, 2024 |
| Ex-Dividend Date | May 31, 2024 |
Share Statistics
MLAB has 5.39 million shares outstanding. The number of shares has increased by 0.67% in one year.
| Shares Outstanding | 5.39M |
| Shares Change (YoY) | +0.67% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 5.74% |
| Owned by Institutions (%) | 92.31% |
| Float | 5.19M |
Valuation Ratios
The trailing PE ratio is 608.76 and the forward PE ratio is 35.21.
| PE Ratio | 608.76 |
| Forward PE | 35.21 |
| PS Ratio | 2.61 |
| Forward PS | 2.34 |
| PB Ratio | 1.38 |
| P/FCF Ratio | 13.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.55, with an EV/FCF ratio of 18.69.
| EV / Earnings | 802.83 |
| EV / Sales | 3.58 |
| EV / EBITDA | 19.55 |
| EV / EBIT | 165.60 |
| EV / FCF | 18.69 |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.68 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 5.98 |
| Debt / FCF | 5.72 |
| Interest Coverage | 0.89 |
Financial Efficiency
Return on equity (ROE) is 0.20% and return on invested capital (ROIC) is 0.63%.
| Return on Equity (ROE) | 0.20% |
| Return on Assets (ROA) | 0.10% |
| Return on Capital (ROIC) | 0.63% |
| Revenue Per Employee | $304,977 |
| Profits Per Employee | $1,358 |
| Employee Count | 698 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | -1.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.37% in the last 52 weeks. The beta is 0.83, so MLAB's price volatility has been lower than the market average.
| Beta (1Y) | 0.83 |
| 52-Week Price Change | -38.37% |
| 50-Day Moving Average | 104.80 |
| 200-Day Moving Average | 107.86 |
| Relative Strength Index (RSI) | 47.07 |
| Average Volume (30 Days) | 43,535 |
Short Selling Information
The latest short interest is 156,011, so 2.89% of the outstanding shares have been sold short.
| Short Interest | 156,011 |
| Short Previous Month | 191,016 |
| Short % of Shares Out | 2.89% |
| Short % of Float | 3.01% |
| Short Ratio (days to cover) | 5.05 |
Income Statement
In the last 12 months, MLAB had revenue of $212.87 million and earned $948,000 in profits. Earnings per share was $0.17.
| Revenue | 212.87M |
| Gross Profit | 129.90M |
| Operating Income | 4.01M |
| Pretax Income | -593,000 |
| Net Income | 948,000 |
| EBITDA | 38.93M |
| EBIT | 4.60M |
| Earnings Per Share (EPS) | $0.17 |
Balance Sheet
The company has $28.22 million in cash and $232.97 million in debt, giving a net cash position of -$204.74 million or -$37.96 per share.
| Cash & Cash Equivalents | 28.22M |
| Total Debt | 232.97M |
| Net Cash | -204.74M |
| Net Cash Per Share | -$37.96 |
| Equity / Book Value | 402.96M |
| Book Value Per Share | 74.70 |
| Working Capital | 74.17M |
Cash Flow
In the last 12 months, operating cash flow was $43.77 million and capital expenditures -$3.06 million, giving a free cash flow of $40.71 million.
| Operating Cash Flow | 43.77M |
| Capital Expenditures | -3.06M |
| Free Cash Flow | 40.71M |
| FCF Per Share | $7.55 |
Margins
Gross margin is 61.02%, with operating and profit margins of 1.88% and 0.45%.
| Gross Margin | 61.02% |
| Operating Margin | 1.88% |
| Pretax Margin | -0.28% |
| Profit Margin | 0.45% |
| EBITDA Margin | 18.29% |
| EBIT Margin | 2.16% |
| FCF Margin | 19.12% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.62%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.62% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 376.47% |
| Buyback Yield | -0.67% |
| Shareholder Yield | -0.05% |
| Earnings Yield | 0.17% |
| FCF Yield | 7.32% |
Analyst Forecast
The average price target for MLAB is $130.00, which is 25.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $130.00 |
| Price Target Difference | 25.62% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.55 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 5 |